nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—NR3C2—dilated cardiomyopathy	0.345	1	CbGaD
Prednisolone—NR3C2—Spironolactone—dilated cardiomyopathy	0.177	0.562	CbGbCtD
Prednisolone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0586	0.186	CbGbCtD
Prednisolone—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0505	0.16	CbGbCtD
Prednisolone—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0474	0.15	CrCrCtD
Prednisolone—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0348	0.11	CrCrCtD
Prednisolone—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.0337	0.107	CrCrCtD
Prednisolone—Testolactone—Spironolactone—dilated cardiomyopathy	0.0327	0.104	CrCrCtD
Prednisolone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0301	0.0954	CrCrCtD
Prednisolone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0293	0.093	CrCrCtD
Prednisolone—Progesterone—Spironolactone—dilated cardiomyopathy	0.0293	0.093	CrCrCtD
Prednisolone—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0286	0.0906	CrCrCtD
Prednisolone—Testosterone—Spironolactone—dilated cardiomyopathy	0.0254	0.0807	CrCrCtD
Prednisolone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.0239	0.0758	CrCrCtD
Prednisolone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0155	0.0491	CbGbCtD
Prednisolone—ABCB1—Spironolactone—dilated cardiomyopathy	0.0136	0.0432	CbGbCtD
Prednisolone—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00156	0.0817	CcSEcCtD
Prednisolone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0014	0.073	CcSEcCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00101	0.277	CbGpPWpGaD
Prednisolone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000793	0.0414	CcSEcCtD
Prednisolone—Blister—Furosemide—dilated cardiomyopathy	0.000584	0.0305	CcSEcCtD
Prednisolone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000556	0.412	CrCbGaD
Prednisolone—Vasculitis—Furosemide—dilated cardiomyopathy	0.000431	0.0225	CcSEcCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000423	0.116	CbGpPWpGaD
Prednisolone—NR3C2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.000361	0.0992	CbGpPWpGaD
Prednisolone—Betamethasone—NR3C2—dilated cardiomyopathy	0.000358	0.265	CrCbGaD
Prednisolone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000353	0.0184	CcSEcCtD
Prednisolone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000351	0.0184	CcSEcCtD
Prednisolone—Viral infection—Lisinopril—dilated cardiomyopathy	0.00035	0.0183	CcSEcCtD
Prednisolone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000347	0.0181	CcSEcCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000325	0.0894	CbGpPWpGaD
Prednisolone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000324	0.0169	CcSEcCtD
Prednisolone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00032	0.0167	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000316	0.0165	CcSEcCtD
Prednisolone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000314	0.0164	CcSEcCtD
Prednisolone—Malaise—Spironolactone—dilated cardiomyopathy	0.000305	0.0159	CcSEcCtD
Prednisolone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.0003	0.0157	CcSEcCtD
Prednisolone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000297	0.0155	CcSEcCtD
Prednisolone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000285	0.0149	CcSEcCtD
Prednisolone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000281	0.0147	CcSEcCtD
Prednisolone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000276	0.0144	CcSEcCtD
Prednisolone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00027	0.0141	CcSEcCtD
Prednisolone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000266	0.0139	CcSEcCtD
Prednisolone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000264	0.0138	CcSEcCtD
Prednisolone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000259	0.0135	CcSEcCtD
Prednisolone—Injury—Lisinopril—dilated cardiomyopathy	0.00025	0.013	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000237	0.0124	CcSEcCtD
Prednisolone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000229	0.012	CcSEcCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000229	0.0629	CbGpPWpGaD
Prednisolone—Progesterone—NR3C2—dilated cardiomyopathy	0.000228	0.169	CrCbGaD
Prednisolone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000228	0.0119	CcSEcCtD
Prednisolone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000219	0.0115	CcSEcCtD
Prednisolone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000218	0.0114	CcSEcCtD
Prednisolone—Dexamethasone—NR3C2—dilated cardiomyopathy	0.000208	0.154	CrCbGaD
Prednisolone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000204	0.0106	CcSEcCtD
Prednisolone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000203	0.0106	CcSEcCtD
Prednisolone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000194	0.0102	CcSEcCtD
Prednisolone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000193	0.0101	CcSEcCtD
Prednisolone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000189	0.00987	CcSEcCtD
Prednisolone—Erythema—Furosemide—dilated cardiomyopathy	0.000184	0.00961	CcSEcCtD
Prednisolone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000183	0.00954	CcSEcCtD
Prednisolone—Weight increased—Lisinopril—dilated cardiomyopathy	0.00018	0.00942	CcSEcCtD
Prednisolone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000174	0.0091	CcSEcCtD
Prednisolone—Rash—Spironolactone—dilated cardiomyopathy	0.000174	0.00909	CcSEcCtD
Prednisolone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000174	0.00909	CcSEcCtD
Prednisolone—Vision blurred—Furosemide—dilated cardiomyopathy	0.000174	0.00906	CcSEcCtD
Prednisolone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000173	0.00905	CcSEcCtD
Prednisolone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000173	0.00905	CcSEcCtD
Prednisolone—Headache—Spironolactone—dilated cardiomyopathy	0.000173	0.00904	CcSEcCtD
Prednisolone—Vertigo—Furosemide—dilated cardiomyopathy	0.000165	0.00864	CcSEcCtD
Prednisolone—Nausea—Spironolactone—dilated cardiomyopathy	0.000164	0.00857	CcSEcCtD
Prednisolone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000162	0.00844	CcSEcCtD
Prednisolone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00015	0.00785	CcSEcCtD
Prednisolone—Shock—Furosemide—dilated cardiomyopathy	0.000148	0.00772	CcSEcCtD
Prednisolone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000145	0.00759	CcSEcCtD
Prednisolone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000142	0.0074	CcSEcCtD
Prednisolone—Erythema—Lisinopril—dilated cardiomyopathy	0.000138	0.00721	CcSEcCtD
Prednisolone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000135	0.00705	CcSEcCtD
Prednisolone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00013	0.0068	CcSEcCtD
Prednisolone—Pain—Furosemide—dilated cardiomyopathy	0.000128	0.00671	CcSEcCtD
Prednisolone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000128	0.00669	CcSEcCtD
Prednisolone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000126	0.00659	CcSEcCtD
Prednisolone—Malaise—Lisinopril—dilated cardiomyopathy	0.000125	0.00651	CcSEcCtD
Prednisolone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000124	0.00648	CcSEcCtD
Prednisolone—Syncope—Lisinopril—dilated cardiomyopathy	0.000124	0.00647	CcSEcCtD
Prednisolone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000124	0.00647	CcSEcCtD
Prednisolone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000121	0.00634	CcSEcCtD
Prednisolone—Urticaria—Furosemide—dilated cardiomyopathy	0.000119	0.00623	CcSEcCtD
Prednisolone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000116	0.00607	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000114	0.0315	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000113	0.00589	CcSEcCtD
Prednisolone—Oedema—Lisinopril—dilated cardiomyopathy	0.000113	0.00589	CcSEcCtD
Prednisolone—Shock—Lisinopril—dilated cardiomyopathy	0.000111	0.00579	CcSEcCtD
Prednisolone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000111	0.00578	CcSEcCtD
Prednisolone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00011	0.00575	CcSEcCtD
Prednisolone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000109	0.00569	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000107	0.0295	CbGpPWpGaD
Prednisolone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000102	0.00532	CcSEcCtD
Prednisolone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000101	0.00529	CcSEcCtD
Prednisolone—Dizziness—Furosemide—dilated cardiomyopathy	9.94e-05	0.00519	CcSEcCtD
Prednisolone—Pain—Lisinopril—dilated cardiomyopathy	9.64e-05	0.00503	CcSEcCtD
Prednisolone—Rash—Furosemide—dilated cardiomyopathy	9.47e-05	0.00495	CcSEcCtD
Prednisolone—Dermatitis—Furosemide—dilated cardiomyopathy	9.46e-05	0.00494	CcSEcCtD
Prednisolone—Headache—Furosemide—dilated cardiomyopathy	9.41e-05	0.00492	CcSEcCtD
Prednisolone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	9.29e-05	0.00485	CcSEcCtD
Prednisolone—Urticaria—Lisinopril—dilated cardiomyopathy	8.96e-05	0.00468	CcSEcCtD
Prednisolone—Nausea—Furosemide—dilated cardiomyopathy	8.92e-05	0.00466	CcSEcCtD
Prednisolone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	8.31e-05	0.00434	CcSEcCtD
Prednisolone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	7.55e-05	0.0208	CbGpPWpGaD
Prednisolone—Dizziness—Lisinopril—dilated cardiomyopathy	7.45e-05	0.00389	CcSEcCtD
Prednisolone—Rash—Lisinopril—dilated cardiomyopathy	7.11e-05	0.00371	CcSEcCtD
Prednisolone—Dermatitis—Lisinopril—dilated cardiomyopathy	7.1e-05	0.00371	CcSEcCtD
Prednisolone—Headache—Lisinopril—dilated cardiomyopathy	7.06e-05	0.00369	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	6.75e-05	0.0186	CbGpPWpGaD
Prednisolone—Nausea—Lisinopril—dilated cardiomyopathy	6.7e-05	0.0035	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	5.58e-05	0.0153	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	4.81e-05	0.0132	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	3.9e-05	0.0107	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	3.56e-05	0.0098	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.53e-05	0.0097	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	3.09e-05	0.0085	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.01e-05	0.00827	CbGpPWpGaD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	2.97e-05	0.00817	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	2.89e-05	0.00795	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.83e-05	0.00778	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	2.75e-05	0.00756	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	2.6e-05	0.00714	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	2.14e-05	0.00588	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.04e-05	0.00561	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.98e-05	0.00545	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.98e-05	0.00545	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	1.98e-05	0.00544	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	1.88e-05	0.00516	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.84e-05	0.00507	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	1.8e-05	0.00495	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NPPA—dilated cardiomyopathy	1.7e-05	0.00467	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	1.69e-05	0.00464	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	1.63e-05	0.00448	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	1.58e-05	0.00435	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	1.51e-05	0.00415	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	1.4e-05	0.00385	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	1.35e-05	0.00372	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.34e-05	0.00368	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	1.26e-05	0.00346	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	1.24e-05	0.00341	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	1.14e-05	0.00313	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	9.64e-06	0.00265	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	9.52e-06	0.00262	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	9.06e-06	0.00249	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.73e-06	0.0024	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.49e-06	0.00233	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.49e-06	0.00233	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	8.19e-06	0.00225	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.89e-06	0.00217	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	7.17e-06	0.00197	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.95e-06	0.00191	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.92e-06	0.0019	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.77e-06	0.00186	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.67e-06	0.00183	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.54e-06	0.0018	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.2e-06	0.0017	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.09e-06	0.00168	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	5.98e-06	0.00164	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	5.74e-06	0.00158	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	5.74e-06	0.00158	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.39e-06	0.00148	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.88e-06	0.00134	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.33e-06	0.00119	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.02e-06	0.00111	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.53e-06	0.000972	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.32e-06	0.000914	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	3.09e-06	0.000851	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	3.01e-06	0.000829	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3e-06	0.000826	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.97e-06	0.000818	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.83e-06	0.000779	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	2.71e-06	0.000746	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	2.23e-06	0.000612	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	2.17e-06	0.000596	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	1.95e-06	0.000537	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.72e-06	0.000473	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.32e-06	0.000364	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.29e-06	0.000355	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.16e-06	0.000319	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.16e-07	0.000224	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.95e-07	0.000219	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.16e-07	0.000197	CbGpPWpGaD
